Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture-Reference-Cited by-同舟云学术

Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture

Published:2007-09-01 Issue:1 Volume:98 Page:141-154
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnol. Bioeng.

Author:

Yang Jeng-Dar,Lu Canghai,Stasny Brad,Henley Joseph,Guinto Woodrow,Gonzalez Carlos,Gleason Joseph,Fung Monica,Collopy Brett,Benjamino Michael,Gangi Jennifer,Hanson Melissa,Ille Elisabeth

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference19 articles.

1. A flow cytometric study of hydrodynamic damage to mammalian cells

2. OLIGOSACCHARIDES, JUST THE ICING ON THE PROTEIN OR ARE THEY OF FUNCTIONAL RELEVANCE?

3. Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?

4. , , , . 2001. Scale-up considerations for biotechnology-derived products. In: editor. Pharmaceutical process scale-up. New York: Marcel Dekker. p 95–114.

5. Characterizing biological products and assessing comparability following manufacturing changes

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An industrial perspective on metabolic responses of Penicillium chrysogenum to periodic dissolved oxygen feast‐famine cycles in a scale‐down system;Biotechnology and Bioengineering;2024-06-22

2. Induction of heat shock protein expression in SP2/0 transgenic cells and its effect on the production of monoclonal antibodies;PLOS ONE;2024-05-02

3. Modeling scalability of impurity precipitation in downstream biomanufacturing;Biotechnology Progress;2024-03-27

4. Review on the Impact of Impeller‐induced Hydrodynamics on Suspension Cell Culture for Production of Biopharmaceuticals;Chemie Ingenieur Technik;2024-02-20

5. Scale-up of cell-culture bioreactors;Bioreactor Design Concepts for Viral Vaccine Production;2024